{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T15:29:47Z","timestamp":1783178987591,"version":"3.54.6"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmech.2021.114026","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T10:24:13Z","timestamp":1638613453000},"page":"114026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["2-(2-Hydroxyethyl)piperazine derivatives as potent human carbonic anhydrase inhibitors: Synthesis, enzyme inhibition, computational studies and antiglaucoma activity"],"prefix":"10.1016","volume":"228","author":[{"given":"Niccol\u00f2","family":"Chiaramonte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5143-9959","authenticated-orcid":false,"given":"Silvia","family":"Sgambellone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Bonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3342-702X","authenticated-orcid":false,"given":"Alessio","family":"Nocentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Bartolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Braconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0898-7148","authenticated-orcid":false,"given":"Silvia","family":"Dei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9016-8429","authenticated-orcid":false,"given":"Laura","family":"Lucarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Teodori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9137-2509","authenticated-orcid":false,"given":"Paola","family":"Gratteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"W\u00fcnsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4262-0323","authenticated-orcid":false,"given":"Claudiu T.","family":"Supuran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5685-3403","authenticated-orcid":false,"given":"Maria Novella","family":"Romanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.114026_bib1","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Supuran, Structure and function of carbonic anhydrases","volume":"473","author":"Claudiu","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejmech.2021.114026_bib2","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/s41396-019-0426-8","article-title":"A\u00a0new widespread subclass of carbonic anhydrase in marine phytoplankton","volume":"13","author":"Jensen","year":"2019","journal-title":"ISME J."},{"key":"10.1016\/j.ejmech.2021.114026_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11099-017-0685-4","article-title":"Carbonic anhydrase \u2014 a universal enzyme of the carbon-based life","volume":"55","author":"Kupriyanova","year":"2017","journal-title":"Photosynthetica"},{"key":"10.1016\/j.ejmech.2021.114026_bib4","series-title":"Carbonic Anhydrases as Biocatalysts - from Theory to Medical and Industrial Applications","article-title":"Carbonic anhydrases: an overview","author":"Supuran","year":"2015"},{"key":"10.1016\/j.ejmech.2021.114026_bib5","series-title":"Drug Design of Zinc-Enzyme Inhibitors: Functional, Structural, and Disease Applications","first-page":"13","article-title":"Carbonic anhydrases as drug targets: general presentation","author":"Supuran","year":"2009"},{"key":"10.1016\/j.ejmech.2021.114026_bib6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/17460441.2019.1651289","article-title":"Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery","volume":"14","author":"Nocentini","year":"2019","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.114026_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.114026_bib8","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/152702903769192359","article-title":"Efficacy of low-dose acetazolamide for the prophylaxis of acute mountain sickness","volume":"4","author":"Dumont","year":"2003","journal-title":"High Alt. Med. Biol."},{"key":"10.1016\/j.ejmech.2021.114026_bib9","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1517\/13543776.2013.782394","article-title":"Anticonvulsant\/antiepileptic carbonic anhydrase inhibitors: a patent review","volume":"23","author":"Aggarwal","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.114026_bib10","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/13543776.2019.1679117","article-title":"Carbonic anhydrase inhibition and the management of glaucoma: a literature and patent review 2013-2019","volume":"29","author":"Supuran","year":"2019","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.114026_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/jop.2014.0067","article-title":"Pharmacotherapy of glaucoma","volume":"31","author":"Schmidl","year":"2015","journal-title":"J.\u00a0Ocul. Pharmacol. Therapeut."},{"key":"10.1016\/j.ejmech.2021.114026_bib12","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/med.21713","article-title":"Progress in the development of human carbonic anhydrase inhibitors and their pharmacological applications: where are we today?","volume":"40","author":"Mishra","year":"2020","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2021.114026_bib13","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1167\/iovs.08-2487","article-title":"Studies on bicarbonate transporters and carbonic anhydrase in porcine nonpigmented ciliary epithelium","volume":"50","author":"Shahidullah","year":"2009","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejmech.2021.114026_bib14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/jmg.40.4.257","article-title":"Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma","volume":"40","author":"Liao","year":"2003","journal-title":"J.\u00a0Med. Genet."},{"key":"10.1016\/j.ejmech.2021.114026_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114026_bib16","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2021.114026_bib17","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17460441.2013.795145","article-title":"Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors","volume":"8","author":"De Simone","year":"2013","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.ejmech.2021.114026_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1517\/13543776.2013.794788","article-title":"Antiglaucoma carbonic anhydrase inhibitors: a patent review","volume":"23","author":"Masini","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ejmech.2021.114026_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1152\/physrev.1967.47.4.595","article-title":"Carbonic anhydrase: chemistry, physiology, and inhibition","volume":"47","author":"Maren","year":"1967","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2021.114026_bib20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ejmech.2018.04.002","article-title":"2-Benzylpiperazine: a new scaffold for potent human carbonic anhydrase inhibitors. Synthesis, enzyme inhibition, enantioselectivity, computational and crystallographic studies and in\u00a0vivo activity for a new class of intraocular pressure lowering agents","volume":"151","author":"Chiaramonte","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114026_bib21","doi-asserted-by":"crossref","first-page":"103130","DOI":"10.1016\/j.bioorg.2019.103130","article-title":"Sulfonamides incorporating piperazine bioisosteres as potent human carbonic anhydrase I, II, IV and IX inhibitors","volume":"91","author":"Chiaramonte","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.114026_bib22","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1021\/jm401707t","article-title":"Synthesis, pharmacological evaluation, and \u03c31 receptor interaction analysis of hydroxyethyl substituted piperazines","volume":"57","author":"Weber","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114026_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/00397918708063919","article-title":"Debenzylation of N-benzylamino derivatives by catalytic transfer hydrtyation with ammonium formate","volume":"17","author":"Ram","year":"1987","journal-title":"Synth. Commun."},{"key":"10.1016\/j.ejmech.2021.114026_bib24","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1163\/156856700X00480","article-title":"Ammonium formate decomposition using palladium catalyst","volume":"26","author":"Dobrovoln\u00e1","year":"2000","journal-title":"Res. Chem. Intermed."},{"key":"10.1016\/j.ejmech.2021.114026_bib25","doi-asserted-by":"crossref","first-page":"10597","DOI":"10.1021\/ja00147a032","article-title":"Total synthesis of (-)-Altemicidin: a novel exploitation of the potier-polonovski rearrangement","volume":"117","author":"Kende","year":"1995","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2021.114026_bib26","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/slct.201702943","article-title":"An efficient one-pot synthesis of chiral N-protected 3-substituted (Diketo)piperazines via Ugi-4CR\/de-boc\/cyclization process","volume":"3","author":"Jida","year":"2018","journal-title":"ChemistrySelect"},{"key":"10.1016\/j.ejmech.2021.114026_bib27","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1039\/C7NJ04039C","article-title":"Efficient one-pot synthesis of enantiomerically pure N-protected-\u03b1-substituted piperazines from readily available \u03b1-amino acids","volume":"42","author":"Jida","year":"2018","journal-title":"New J. Chem."},{"key":"10.1016\/j.ejmech.2021.114026_bib28","unstructured":"A Closer Inspection of Refs.\u00a026,27showed that These Researchers Claimed This Procedure as a General Method to Obtain Enantiopure Piperazinediones from Aminoacids, but They Did Not Apply This Approach to Aspartic Acid."},{"key":"10.1016\/j.ejmech.2021.114026_bib29","series-title":"Azabenzoxazoles for the Treatment of CNS Disorders","author":"Belyankin","year":"2006"},{"key":"10.1016\/j.ejmech.2021.114026_bib30","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0040-4020(01)01212-1","article-title":"Synthesis of chiral non-racemic 3-(dioxopiperazin-2-yl)propionic acid derivatives","volume":"58","author":"Weigl","year":"2002","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2021.114026_bib31","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/S0021-9258(18)62326-9","article-title":"The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C","volume":"246","author":"Khalifah","year":"1971","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.114026_bib32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.3390\/ijms20040981","article-title":"Role of histamine H3 receptor antagonists on intraocular pressure reduction in rabbit models of transient ocular hypertension and glaucoma","volume":"20","author":"Lanzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2021.114026_bib33","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1146\/annurev.anchem.1.031207.112945","article-title":"High-resolution mass spectrometers","volume":"1","author":"Marshall","year":"2008","journal-title":"Annu. Rev. Anal. Chem."},{"key":"10.1016\/j.ejmech.2021.114026_bib34","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cbdd.13586","article-title":"Development of bisubstrate analog inhibitors of aspartate N-acetyltransferase, a critical brain enzyme","volume":"95","author":"Mutthamsetty","year":"2020","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2021.114026_bib35","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.tetlet.2018.04.030","article-title":"Asymmetric syntheses of (R)-4-halo-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines, important 5-HT2C agonist precursors","volume":"59","author":"Schrader","year":"2018","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.114026_bib36","series-title":"Piperazine Substituted Aryl Benzodiazepines and Their Use as Dopamine Receptor Antagonists for the Treatment of Psychotic Disorders. WO03082877 A1","author":"Aicher","year":"2003"},{"key":"10.1016\/j.ejmech.2021.114026_bib37","doi-asserted-by":"crossref","first-page":"151697","DOI":"10.1016\/j.tetlet.2020.151697","article-title":"Synthesis of (+)- and (\u2212)-Geissman-Waiss lactone from chiral sulfonium salts","volume":"61","author":"L\u00f3pez-Gonz\u00e1lez","year":"2020","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2021.114026_bib38","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/jm050333c","article-title":"Carbonic anhydrase inhibitors:stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X -rayCrystal structure of a membrane -ImpermeantAntitumor sulfonamide complexed with isozyme II","volume":"48","author":"Menchise","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114026_bib39","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1107\/S0907444910006554","article-title":"Atomic resolution studies of carbonic anhydrase II","volume":"66","author":"Behnke","year":"2010","journal-title":"Acta Crystallogr. D"},{"key":"10.1016\/j.ejmech.2021.114026_bib40","doi-asserted-by":"crossref","first-page":"D437","DOI":"10.1093\/nar\/gkaa1038","article-title":"RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences","volume":"49","author":"Burley","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2021.114026_bib41","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1073\/pnas.93.24.13589","article-title":"Crystal structure of the secretory form of membrane-associated human carbonic anhydrase IV at 2.8-\u00c5 resolution","volume":"93","author":"Stams","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2021.114026_bib42","doi-asserted-by":"crossref","first-page":"9004","DOI":"10.1021\/acs.jmedchem.5b01343","article-title":"Efficient expression and crystallization system of cancer-associated carbonic anhydrase isoform IX","volume":"58","author":"Leitans","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.114026_bib43","series-title":"Schr\u00f6dinger Suite Release 2019-1","author":"Schr\u00f6dinger","year":"2019"},{"key":"10.1016\/j.ejmech.2021.114026_sref44","unstructured":"Maestro v.11.9;."},{"key":"10.1016\/j.ejmech.2021.114026_bib43b","unstructured":"Epik, v.4.7."},{"key":"10.1016\/j.ejmech.2021.114026_bib43c","unstructured":"Impact, v.8.2;."},{"key":"10.1016\/j.ejmech.2021.114026_bib43d","unstructured":"Prime, v.5.5;."},{"key":"10.1016\/j.ejmech.2021.114026_bib43e","unstructured":"Macromodel v.12.3."},{"key":"10.1016\/j.ejmech.2021.114026_bib43f","unstructured":"Glide, v.8.2;."},{"key":"10.1016\/j.ejmech.2021.114026_bib43g","unstructured":"Desmond, 5.7."},{"key":"10.1016\/j.ejmech.2021.114026_bib44","doi-asserted-by":"crossref","first-page":"6474","DOI":"10.1021\/jp003919d","article-title":"Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides","volume":"105","author":"Kaminski","year":"2001","journal-title":"J.\u00a0Phys. Chem. B"},{"key":"10.1016\/j.ejmech.2021.114026_bib45","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/prot.21123","article-title":"Comparison of multiple Amber force fields and development of improved protein backbone parameters","volume":"65","author":"Hornak","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2021.114026_bib46","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1021\/acs.jctc.8b01026","article-title":"OPLS3e: extending Force Field Coverage for Drug-Like Small Molecules","volume":"15","author":"Roos","year":"2019","journal-title":"J.\u00a0Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2021.114026_bib47","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2014a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J.\u00a0Comput. Chem."},{"key":"10.1016\/j.ejmech.2021.114026_bib48","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0039-6257(01)00211-9","article-title":"The Draize eye test","volume":"45","author":"Wilhelmus","year":"2001","journal-title":"Surv. Ophthalmol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:35:12Z","timestamp":1759329312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421008758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":55,"alternative-id":["S0223523421008758"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.114026","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2-(2-Hydroxyethyl)piperazine derivatives as potent human carbonic anhydrase inhibitors: Synthesis, enzyme inhibition, computational studies and antiglaucoma activity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.114026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114026"}}